(Q77302574)
Statements
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer (English)
M Mackean
A Planting
J Schellens
D Allman
B Osterwalder
B Reigner
T Griffin
S Kaye
1 September 1998